Browse Gastrointestinal diseases topic

Drug therapy subtopic

Articles 1-15 out of 15 article(s) Title Author Type Date Words Manufacturer withdraws Accutane; Study bolsters link to bowel disease; Generic versions of acne drug available. Nov 8, 2009 1066 NIH Issues $2.87 Million Grant for Development of Ceragenin[TM] Based Drug to Treat Clostridium difficile and Shigella Gastrointestinal Infections. Sep 9, 2009 1121 Development of intestinal flora in infancy and its effects on immune system/Bebeklikte barsak florasi gelisimi ve immun sisteme etkileri. Kultursay, Nilgun Report Jun 1, 2009 3175 Synergy Pharmaceuticals to Present Phase I Volunteer Study on SP-304 Investigational Drug to Treat GI Disorders at Upcoming Conference. Conference news May 26, 2009 572 Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. Lee, Tae Ho; Choi, Jeong June; Kim, Dong Hee; Seok; Choi; Lee, Kang Ro; Son, Miwon; Jin, Mirim Report Oct 1, 2008 4731 Callisto Announces Guanilib Presentation at the 5th Annual Meeting of Cancer Drugs Research and Development. Conference news Feb 19, 2008 760 IRISH DOCS HOPE FOR BOWEL DISEASE CURE; New drugs to help 15,000. Jan 15, 2008 198 U.S. jury awards $2.5 million in Roche Accutane trial. Brief article Jun 4, 2007 262 Anti-inflammatories, arthritis and gastric outcomes. Farham, Bridget Clinical report May 1, 2007 510 Novartis pulls Zelnorm at FDA request due to heart disease risks. Apr 9, 2007 588 Novel agent improves GI function in pain patients. Nelson, Roxanne Oct 1, 2006 533 Santarus Receives FDA Approval for ZEGERID with Magnesium Hydroxide Chewable Tablets. Mar 27, 2006 1056 GUANILIB DRUG CANDIDATE FOR GI DISEASE MOVES TO CLINICAL TRIAL. Feb 1, 2006 539 Callisto Establishes Guanilib as Developmental Name for Novel Drug Candidate for GI Disease; Name Established as Company Moves Forward with First-in-Class Compound Planned for Clinical Trial. Dec 22, 2005 753 Solutions for an upset stomach. Brief Article Nov 8, 2005 242